Fluxergy
Portable diagnostic platform for rapid tests
Manufacturing Operator
About the job
- Strong hand-eye coordination and attention to detail.
- Ability to operate machinery safely and responsibly.
- Demonstrated commitment to safe work practices when interacting with machinery.
- Ability to maintain a clean and organized workspace.
- Basic computer proficiency, including Microsoft Word, Excel, and PowerPoint.
- Ability to stand for extended periods during the workday.
- Assemble the components that make up the Test Card consumable with accuracy and consistency.
- Operate industrial and custom automation machinery safely and effectively.
- Follow established production procedures and detailed process work instructions.
- Inspect products to ensure they meet defined quality and performance specifications.
- Maintain accurate production records, logs, and documentation.
- Support daily production operations while maintaining high standards of safety and efficiency.
- Keep work areas, equipment, and machinery clean, organized, and production-ready.
- Assist with monitoring and maintaining product and material inventory levels.
- Collaborate with team members to maintain a smooth and productive workflow.
- Perform additional tasks or support duties as needed to meet production goals.
- Experience operating production or manufacturing equipment.
- Previous experience working in a manufacturing or production environment.
About the company
Fluxergy creates a portable diagnostic platform that lets healthcare providers, veterinarians (including equine), and food-safety teams run multiple diagnostic tests on a single device, delivering rapid results at point-of-care. The system combines the device with disposable test kits to perform various tests, from molecular assays like COVID-19 to other health and safety checks, and is designed for fast, on-site decision-making. Fluxergy differentiates itself by offering industry-specific applications and a scalable, end-to-end solution (device plus kits) that targets diverse PoC settings, backed by partnerships and validated through collaborations with institutions such as Mass General Brigham. The company aims to expand production and adoption to set new benchmarks in how quickly and reliably laboratory testing can be done in real-world environments.
Company Size
51-200
Company Stage
Series C
Total Funding
$49.5M
Headquarters
Irvine, California
Founded
2011
Get referred to Fluxergy
See people who can refer or advise you
Simplify's Take
What believers are saying
- NIH collaboration advanced in January 2025, with clinical trials targeted for 2025.
- Fluxergy reported over 100,000 test cartridges manufactured by July 2026.
- The Irvine expansion and new assay launches support broader European and veterinary sales.
What critics are saying
- Headcount fell from 125 in 2023 to 82 in March 2026, signaling contraction.
- Fluxergy still lacks FDA EUA for its core platform, limiting U.S. revenue conversion.
- If NIH-backed STI trials slip past 2026, the company risks another commercialization stall.
What makes Fluxergy unique
- Fluxergy's all-in-one analyzer compresses PCR, point-of-care, and sample prep into one platform.
- NIH NIAID selected Fluxergy in 2024 for Diagnostics Development Services, signaling technical credibility.
- Its veterinary and human infectious-disease menus create cross-market reuse across labs and clinics.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 0%2 year growth
↓ -7%Fluxergy partners with National Institutes of Health.
Fluxergy started its commercial launch of its in-house PCR platform in late 2022 and is now being used in over 80 veterinary labs and referral hospitals in the US, Canada and EU.
"We are proud to offer an on-site solution and comprehensive laboratory training that can make a difference in how care providers navigate preventative and responsive pathogen testing.". .
IRVINE, CA., July 2, 2020 – California-based Fluxergy will work with Mass General Brigham (MGB), a major health system in Massachusetts, to further evaluate Fluxergy’s innovative Research Use Only (RUO) COVID-19 testing platform, designed to deliver accurate PCR test results in under one hour.
In March, Fluxergy announced that it was similarly working with a team at the University of California, San Diego, to evaluate its system for COVID-19 testing.